Andrew Cittadine

Insider Reports History

Location
Wilmette, IL
Signature
/s/ Quan Vu, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Cittadine:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monopar Therapeutics Chief Operating Officer Common Stock 50,726 $3,312,407 $65.30 31 Dec 2025 Direct
Monopar Therapeutics Chief Operating Officer Restricted Stock Units 52,593 $1,136,410 $22.00 02 Dec 2025 Direct
Monopar Therapeutics Chief Operating Officer Restricted Stock Unit 48,267 31 Dec 2025 Direct
Monopar Therapeutics Chief Operating Officer Stock Options 8,969 02 Dec 2025 Direct

Insider Reports Filed by Andrew Cittadine

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNPR Monopar Therapeutics 31 Dec 2025 3 -$123,352 4 Chief Operating Officer 05 Jan 2026, 15:45
MNPR Monopar Therapeutics 02 Dec 2025 2 $0 4 Chief Operating Officer 08 Dec 2025, 16:50
MNPR Monopar Therapeutics 30 Sep 2025 3 -$154,846 4 Chief Operating Officer 02 Oct 2025, 15:04
MNPR Monopar Therapeutics 30 Jun 2025 3 -$106,982 4 Chief Operating Officer 02 Jul 2025, 16:24
MNPR Monopar Therapeutics 31 Mar 2025 3 -$27,089 4 Chief Operating Officer 02 Apr 2025, 21:08
MNPR Monopar Therapeutics 04 Mar 2025 2 $0 4 Chief Operating Officer 07 Mar 2025, 21:09
MNPR Monopar Therapeutics 31 Dec 2024 3 -$15,862 4 Chief Operating Officer 02 Jan 2025, 18:15
MNPR Monopar Therapeutics 30 Sep 2024 3 -$3,606 4 Chief Operating Officer 02 Oct 2024, 19:44
MNPR Monopar Therapeutics 30 Jun 2024 3 -$1,476 4 Chief Operating Officer 02 Jul 2024, 18:12
MNPR Monopar Therapeutics 18 Jun 2024 2 +$25,574 4 Chief Operating Officer 21 Jun 2024, 17:16
MNPR Monopar Therapeutics 13 Jun 2024 3 +$32,894 4 Chief Operating Officer 17 Jun 2024, 18:08
MNPR Monopar Therapeutics 03 Jun 2024 2 +$18,480 4 Chief Operating Officer 05 Jun 2024, 18:12
MNPR Monopar Therapeutics 29 May 2024 3 +$23,051 4 Chief Operating Officer 31 May 2024, 16:56
MNPR Monopar Therapeutics 22 May 2024 1 $0 4 Chief Operating Officer 24 May 2024, 16:59
MNPR Monopar Therapeutics 31 Mar 2024 3 -$2,110 4 Chief Operating Officer 02 Apr 2024, 20:35
MNPR Monopar Therapeutics 31 Dec 2023 3 -$1,054 4 Chief Operating Officer 03 Jan 2024, 19:39
MNPR Monopar Therapeutics 30 Sep 2023 3 -$1,627 4 Chief Operating Officer 03 Oct 2023, 19:30
MNPR Monopar Therapeutics 30 Jun 2023 3 -$3,469 4 Chief Operating Officer 03 Jul 2023, 18:51
MNPR Monopar Therapeutics 31 Mar 2023 3 -$1,604 4 Chief Operating Officer 04 Apr 2023, 17:15
MNPR Monopar Therapeutics 01 Feb 2023 2 $0 4 Chief Operating Officer 03 Feb 2023, 17:44
MNPR Monopar Therapeutics 31 Dec 2022 3 -$3,332 4 Chief Operating Officer 03 Jan 2023, 15:07
MNPR Monopar Therapeutics 14 Nov 2022 2 +$49,659 4 Chief Operating Officer 16 Nov 2022, 15:58
MNPR Monopar Therapeutics 30 Sep 2022 3 -$1,810 4 Chief Operating Officer 03 Oct 2022, 19:42
MNPR Monopar Therapeutics 30 Jun 2022 3 -$6,465 4 Chief Operating Officer 01 Jul 2022, 16:17
MNPR Monopar Therapeutics 02 Feb 2022 2 $0 4 Chief Operating Officer 04 Feb 2022, 18:29
MNPR Monopar Therapeutics 30 Jun 2021 1 $0 4 Chief Operating Officer 02 Jul 2021, 17:07
MNPR Monopar Therapeutics 01 Jun 2021 1 $0 4 Chief Operating Officer 02 Jun 2021, 16:11
MNPR Monopar Therapeutics 01 Jun 2021 0 $0 3/A Chief Operating Officer 02 Jun 2021, 16:10